Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
14 Février 2025 - 11:10PM
Edgar (US Regulatory)
JOINT FILING APPLICATION
The undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.0001 per share, of PaxMedica, Inc. shall be filed on behalf of each of
the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
February 14, 2025
LIND GLOBAL FUND II LP
|
|
By:
|
Lind Global Partners II LLC
|
|
its General Partner
|
|
|
By:
|
/s/ Jeff Easton
|
Name:
|
Jeff Easton
|
Title:
|
Managing Member
|
|
|
LIND GLOBAL PARTNERS II LLC
|
|
|
By:
|
/s/ Jeff Easton
|
Name:
|
Jeff Easton
|
Title:
|
Managing Member
|
|
JEFF EASTON
|
|
By:
|
|
|
PaxMedica (CE) (USOTC:PXMD)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
PaxMedica (CE) (USOTC:PXMD)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025
Real-Time news about PaxMedica Inc (CE) (OTCMarkets): 0 recent articles
Plus d'articles sur PaxMedica Inc (CE)